Medicare Enrolled
Dr. Thomas Young, MD
Interventional Cardiology · San Diego, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Young from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Young?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Young
Dr. Thomas Young is an interventional cardiology specialist in San Diego, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Young performed 5,763 Medicare services across 2,551 unique beneficiaries.
Between the years covered by Open Payments, Dr. Young received a total of $5,831 from 40 pharmaceutical and/or device companies across 208 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional cardiology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Young is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 19% volume in CA
$5,831 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,763
Medicare services
Top 19% in CA for interventional cardiology
2,551
Unique beneficiaries
$49
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~303 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
1,014 | $42 | $106 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,008 | $70 | $108 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
785 | $46 | $132 |
| Remote vital sign monitoring management, each additional 20 minutes This code covers the time spent by a provider managing patient data from remote vital sign monitoring devices. It applies to each additional 20-minute increment beyond the initial monthly service period. |
444 | $34 | $86 |
| Anticoagulant management for warfarin Management of anticoagulant therapy for a patient taking warfarin. This service involves monitoring and adjusting the medication regimen. |
311 | $9 | $26 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
241 | $8 | $8 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
222 | $12 | $56 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
192 | $166 | $550 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
139 | $16 | $47 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
137 | $10 | $30 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
136 | $42 | $107 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
105 | $8 | $22 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
85 | $10 | $28 |
| Remote physiologic monitoring setup and education Initial setup of remote monitoring equipment and patient education on its use. |
81 | $17 | $38 |
| Technetium Tc-99m tetrofosmin diagnostic injection A diagnostic injection of Technetium Tc-99m tetrofosmin used for imaging studies. |
80 | $76 | $150 |
| New patient office visit, complex (60-74 min) | 75 | $168 | $352 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
75 | $64 | $120 |
| Free thyroxine (T4) test A blood test that measures the level of free thyroxine, a thyroid hormone, in the bloodstream. |
67 | $9 | $26 |
| Lipid panel (cholesterol and triglycerides) A blood test that measures cholesterol and triglyceride levels. |
61 | $13 | $38 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
57 | $170 | $507 |
| Basic metabolic blood panel A blood test that measures a group of basic chemicals, including total calcium levels. |
52 | $8 | $24 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
50 | $55 | $225 |
| Pacemaker system evaluation Assessment of a pacemaker device, including single, dual, multiple lead, or leadless systems. |
49 | $45 | $89 |
| Natriuretic peptide level test A blood test that measures the level of natriuretic peptide, a protein produced by the heart and blood vessels. |
48 | $38 | $95 |
| LDL cholesterol level test A blood test that measures the amount of low-density lipoprotein (LDL) cholesterol in your blood. LDL is often referred to as "bad" cholesterol. |
46 | $10 | $27 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
40 | $401 | $1,123 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
40 | $96 | $153 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
32 | $7 | $35 |
| 2-day continuous ECG with review and report A two-day continuous electrocardiogram recording that includes a professional review and written report of the results. |
21 | $62 | $352 |
| Implantable defibrillator system check A check of the implanted defibrillator device to ensure it is functioning correctly. This evaluation covers single, dual, or multiple lead systems. |
19 | $59 | $136 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
15 | $143 | $304 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
14 | $25 | $116 |
| HDL cholesterol level test A blood test that measures the amount of high-density lipoprotein (HDL) cholesterol in your blood. HDL is often referred to as 'good' cholesterol. |
11 | $8 | $23 |
| Triglyceride level test A blood test that measures the amount of triglycerides, a type of fat, in your blood. |
11 | $6 | $17 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
4.8% high complexity
6.3% medium
88.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$5,831
Total received (2018-2024)
Avg $833/year across 7 years
Bottom 48% in CA for interventional cardiology
40
Companies
208
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,605 (96.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$225 (3.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$462
2023
$745
2022
$1,176
2021
$1,106
2020
$664
2019
$927
2018
$751
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$201
Janssen Pharmaceuticals, Inc
$82
Abbott Laboratories
$46
Kestra Medical Technology Services, Inc.
$33
Philips North America LLC
$26
Kiniksa Pharmaceuticals International, plc
$21
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$20
Amgen Inc.
$19
Boehringer Ingelheim Pharmaceuticals, Inc.
$14
Top 3 companies account for 71.1% of 2024 payments
All-time payments by company (2018-2024) ›
Abbott Laboratories
$721
Novartis Pharmaceuticals Corporation
$514
GlaxoSmithKline, LLC.
$495
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$473
Boehringer Ingelheim Pharmaceuticals, Inc.
$340
Amgen Inc.
$299
Astellas Pharma US Inc
$278
Braemar Manufacturing, LLC
$229
PFIZER INC.
$226
Merck Sharp & Dohme LLC
$223
Janssen Pharmaceuticals, Inc
$214
SANOFI-AVENTIS U.S. LLC
$181
AstraZeneca Pharmaceuticals LP
$175
E.R. Squibb & Sons, L.L.C.
$166
BOSTON SCIENTIFIC CORPORATION
$140
Impulse Dynamics (USA) Inc.
$137
Actelion Pharmaceuticals US, Inc.
$122
Novo Nordisk Inc
$118
Radius Health, Inc.
$106
BIOTRONIK INC.
$80
iRhythm Technologies, Inc.
$53
Gilead Sciences, Inc.
$52
ARBOR PHARMACEUTICALS, INC.
$48
Amarin Pharma Inc.
$43
Coala Life Inc
$41
Bardy Diagnostics, Inc.
$40
Medtronic, Inc.
$34
Kestra Medical Technology Services, Inc.
$33
Philips North America LLC
$26
Shockwave Medical, Inc
$26
Merck Sharp & Dohme Corporation
$24
Baxter Healthcare
$23
Boston Scientific Corporation
$22
Kiniksa Pharmaceuticals International, plc
$21
Medtronic Vascular, Inc.
$21
Alnylam Pharmaceuticals Inc.
$20
Daiichi Sankyo Inc.
$19
Regeneron Healthcare Solutions, Inc.
$16
Kowa Pharmaceuticals America, Inc.
$15
CMP Pharma, Inc.
$13
Top 3 companies account for 29.7% of all-time payments
Associated products mentioned in payments ›
(CK7) Extended Holter · AMVUTTRA · ANORO · ASSURITY · AVEIR · Arcalyst · Assure WCD · BELSOMRA · BIOMONITOR · BRILINTA · CAMZYOS · CHANTIX · CONFIRM RX · Cardiac Monitoring Suite · Carnation Ambulatory Monitor · CaroSpir · Coala Heart Monitor · Confirm Rx · ELIQUIS · ENTRESTO · Edarbi · Edarbyclor · Edora · Hillrom - Cardiac Ambulatory Monitor · INJECTAFER · JARDIANCE · LEQVIO · LEXISCAN · Lexiscan · LifeVest · Livalo · MICRA · MITRACLIP · MULTAQ · Mitra Clip system · Optimizer · Optis Coronary Imaging System · PRADAXA · PRALUENT · Quadra Assura CRT Defibrillator · RYBELSUS · Repatha · Solara · TRELEGY ELLIPTA · Tymlos · VERQUVO · VYNDAQEL · Vascepa · Vascular Lithotripsy · WATCHMAN · WATCHMAN Access System · XARELTO · XIENCE SIERRA · Xience Sierra Coronary Stent · ZIO Patch · ZIO XT Patch
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Interventional cardiologists within 10 mi
30
Per 100K population
0.9
County median income
$102,285
Nearest hospital
KAISER FOUNDATION HOSPITAL - SAN DIEGO
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Young is a clinical cardiology specialist, with above-average Medicare volume (top 19% in CA), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Young experienced with remote patient monitoring management, 20 min/month?
Based on Medicare claims data, Dr. Young performed 1,014 remote patient monitoring management, 20 min/month services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Young receive payments from pharmaceutical companies?
Yes. Dr. Young received a total of $5,831 from 40 companies across 208 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Young's costs compare to other interventional cardiologists in San Diego?
Dr. Young's average Medicare payment per service is $49. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Young) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Interventional Cardiologists in San Diego
Browse interventional cardiologists in San Diego ranked by procedure volume and transparency data.
Highest volume
Top Interventional Cardiologists in CA
Interventional cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Interventional Cardiologists in CA
Which CA interventional cardiologists receive the most from drug and device companies.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology